William B.J. Jones's most recent trade in Apogee Therapeutics Inc. was a trade of 10,370 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on June 5, 2024.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Apogee Therapeutics Inc. | William B.J. Jones | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2024 | 10,370 | 10,370 | - | - | Stock Option (Right to Buy) | |
Akili Inc | William B.J. Jones | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 May 2023 | 22,000 | 22,000 | - | - | Stock Option (Right to Buy) | |
Akili Inc | William B.J. Jones | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Nov 2022 | 44,000 | 44,000 | - | - | Stock Option (Right to Buy) |